Case report: Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy

Carl Boodman; Yashpal S. Chhonker; Daryl J. Murry; Allison Mah; Jennifer Grant; Theodore Steiner; Michael Libman; Cesilia Nishi; Marthe Charles

doi:10.4269/ajtmh.18-0487

Case report: Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy

Carl Boodman, Yashpal S. Chhonker, Daryl J. Murry, Allison Mah, Jennifer Grant, Theodore Steiner, Michael Libman, Cesilia Nishi, Marthe Charles

Research output: Contribution to journal › Article › peer-review

Abstract

Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM). Here, we report elevated plasma IVM and albendazole sulfoxide concentrations in the context of extra-corporeal membrane oxygenation and continuous renal replacement therapyinapatient with disseminated strongyloidiasis treated with subcutaneous IVM and nasogastric albenzadole. Despite elevated drug plasma concentrations, live filariform larvae were detected in endotracheal aspirates after 2 weeks of treatment.

Original language	English (US)
Pages (from-to)	1194-1197
Number of pages	4
Journal	American Journal of Tropical Medicine and Hygiene
Volume	99
Issue number	5
DOIs	https://doi.org/10.4269/ajtmh.18-0487
State	Published - 2018

ASJC Scopus subject areas

Parasitology
Virology
Infectious Diseases

Access to Document

10.4269/ajtmh.18-0487

Cite this

Boodman, C., Chhonker, Y. S., Murry, D. J., Mah, A., Grant, J., Steiner, T., Libman, M., Nishi, C., & Charles, M. (2018). Case report: Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy. American Journal of Tropical Medicine and Hygiene, 99(5), 1194-1197. https://doi.org/10.4269/ajtmh.18-0487

Case report : Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy. / Boodman, Carl; Chhonker, Yashpal S.; Murry, Daryl J.; Mah, Allison; Grant, Jennifer; Steiner, Theodore; Libman, Michael; Nishi, Cesilia; Charles, Marthe.

In: American Journal of Tropical Medicine and Hygiene, Vol. 99, No. 5, 2018, p. 1194-1197.

Research output: Contribution to journal › Article › peer-review

Boodman, C, Chhonker, YS, Murry, DJ, Mah, A, Grant, J, Steiner, T, Libman, M, Nishi, C & Charles, M 2018, 'Case report: Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy', American Journal of Tropical Medicine and Hygiene, vol. 99, no. 5, pp. 1194-1197. https://doi.org/10.4269/ajtmh.18-0487

Boodman, Carl ; Chhonker, Yashpal S. ; Murry, Daryl J. ; Mah, Allison ; Grant, Jennifer ; Steiner, Theodore ; Libman, Michael ; Nishi, Cesilia ; Charles, Marthe. / Case report : Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy. In: American Journal of Tropical Medicine and Hygiene. 2018 ; Vol. 99, No. 5. pp. 1194-1197.

@article{65270579b888497b84a222541b70d1bd,

title = "Case report: Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy",

abstract = "Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM). Here, we report elevated plasma IVM and albendazole sulfoxide concentrations in the context of extra-corporeal membrane oxygenation and continuous renal replacement therapyinapatient with disseminated strongyloidiasis treated with subcutaneous IVM and nasogastric albenzadole. Despite elevated drug plasma concentrations, live filariform larvae were detected in endotracheal aspirates after 2 weeks of treatment.",

author = "Carl Boodman and Chhonker, {Yashpal S.} and Murry, {Daryl J.} and Allison Mah and Jennifer Grant and Theodore Steiner and Michael Libman and Cesilia Nishi and Marthe Charles",

note = "Publisher Copyright: {\textcopyright} 2018 by The American Society of Tropical Medicine and Hygiene.",

year = "2018",

doi = "10.4269/ajtmh.18-0487",

language = "English (US)",

volume = "99",

pages = "1194--1197",

journal = "American Journal of Tropical Medicine and Hygiene",

issn = "0002-9637",

publisher = "American Society of Tropical Medicine and Hygiene",

number = "5",

}

TY - JOUR

T1 - Case report

T2 - Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy

AU - Boodman, Carl

AU - Chhonker, Yashpal S.

AU - Murry, Daryl J.

AU - Mah, Allison

AU - Grant, Jennifer

AU - Steiner, Theodore

AU - Libman, Michael

AU - Nishi, Cesilia

AU - Charles, Marthe

PY - 2018

Y1 - 2018

N2 - Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM). Here, we report elevated plasma IVM and albendazole sulfoxide concentrations in the context of extra-corporeal membrane oxygenation and continuous renal replacement therapyinapatient with disseminated strongyloidiasis treated with subcutaneous IVM and nasogastric albenzadole. Despite elevated drug plasma concentrations, live filariform larvae were detected in endotracheal aspirates after 2 weeks of treatment.

AB - Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM). Here, we report elevated plasma IVM and albendazole sulfoxide concentrations in the context of extra-corporeal membrane oxygenation and continuous renal replacement therapyinapatient with disseminated strongyloidiasis treated with subcutaneous IVM and nasogastric albenzadole. Despite elevated drug plasma concentrations, live filariform larvae were detected in endotracheal aspirates after 2 weeks of treatment.

UR - http://www.scopus.com/inward/record.url?scp=85056272689&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056272689&partnerID=8YFLogxK

U2 - 10.4269/ajtmh.18-0487

DO - 10.4269/ajtmh.18-0487

M3 - Article

C2 - 30226142

AN - SCOPUS:85056272689

VL - 99

SP - 1194

EP - 1197

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 5

ER -

Case report: Ivermectin and Albendazole Plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this